Stem Cell Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Stem Cell Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Stem Cell Research
New findings from M.A. Slavin and co-authors in the area of stem cell research published
August 25th, 2008
"Antifungal prophylaxis can be recommended in patients undergoing induction chemotherapy for acute myeloid leukemia and treatment for grade 2 or greater or chronic extensive graft versus host disease. The evidence for prophylaxis is less clear in other clinical settings although certain groups such as patients with prolonged neutropenia after stem cell transplants using bone marrow or cord blood sources and with impaired cell mediated immunity secondary to treatments such as Alemtuzumab are at high risk," scientists writing in the Internal Medicine Journal report. "The decision to use prophylaxis and which agent to use will be influenced by effectiveness, number...
Source: Stem Cell Week (2008-08-25)
|
